Ciphergen Diagnostics Strategy Includes Fall Ovarian Cancer Test Debut
This article was originally published in The Gray Sheet
Executive Summary
Ciphergen's nascent diagnostics division will be built with research contributed by customers of its ProteinChip research tools unit